• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • Login
  • 0Shopping Cart

  • COVID-19 Resources
  • Knowledge Center
  • Blog
  • Featured
    • View Webinars On-Demand
    • The In Vitro Diagnostics Market: $83 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • Free Downloads
  • About Us
  • Research Index
  • Contact
  • Search
  • Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login

Healthcare Facilities & Settings

  • Sort by Random
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Display 15 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
    Long-Term Care Market – Nursing Homes, Home Care, Hospice Care, and Assisted Living, The

    Published: July 1, 2008 | Price: $3,995 – $7,990

    As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices. The U.S. long care industry has experienced strong growth from 2002 through 2007 and this growth is expected to accelerate through the forecast period as the U.S. population continues to age and demand rises for long term care. Ongoing cost containment...
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)

    Published: September 18, 2020 | Price: $5,500 – $11,000

    What is the Market for Urgent Care Centers?  What Services are they Selling?  Who is Selling Testing and Vaccine Products to Urgent Care? Kalorama's comprehensive report answers these questions, and more. With approximately 10,000 locations across the country, urgent care clinics (UCCs), are an increasingly important of the U.S. health care marketplace. They offer walk-in care and a range of services, expanded hours and limited wait times.  Urgent care centers are not new. There are many urgent care centers in operation...
    The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living

    Published: March 15, 2012 | Price: $3,995 – $7,990

    The advancing age of the population makes long-term care an important consideration for health marketers.  This report, The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care; Home care; Hospice care; Assisted living. Kalorama Information publishes its fourth edition of this detailed report on the...
    The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment)

    Published: August 9, 2013 | Price: $3,995 – $7,990

    This  Kalorama Information report  The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI.  ...
Page 3 of 3123
Knowledge Center Sidebar

Most Popular Research

  • The Worldwide Market for In Vitro Diagnostics, 13th Edition
  • Clinical Diagnostics MasterFile
  • Benchmarking for 2021: Understanding the Clinical Diagnostics Customer Experience
  • Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Watch the Companies That Make Cell and Gene Therapies For Pharma, Says New Report April 16, 2021
  • Global Biomarker Test Product Sales to Reach $63 Billion in 2027 April 14, 2021
  • Global IVD Procedures to Grow to 111.3 Billion Annually…Here’s Why April 7, 2021
  • FDA Approves Novel Cell Therapy for Multiple Myeloma March 30, 2021
  • COVID-19 Diagnostics Market Blog: Qiagen secures EUA for COVID-19 test – Labs Still Struggle with Supplies, Says CAP; Cue Health Gets At-Home Approval; FDA Tightens on Variants March 29, 2021

Sitemap

  • Home
  • About
  • Blog
  • Contact

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Scroll to top
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register